KTTA
Pasithea Therapeutics Corp.
NASDAQ · Healthcare · Biotechnology · US
$0.58
−0.07%Jun 2, 2026, 11:02 UTC
The FDA granted Orphan Drug Designation to Pasithea Therapeutics' PAS-004 for the treatment of ALS.
Source:
NASDAQ · Healthcare · Biotechnology · US
Jun 2, 2026, 11:02 UTC